BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2001
View Archived Issues
Nycomed Amersham reports 2000 highlights, future name change
Read More
Reolysin induces reduction in tumor volume in mouse model
Read More
Ligand signs on Elan as third partner for oncology product commercialization
Read More
Regeneron reports follow-up results of phase II Axokine study
Read More
EpiGenesis enters agreement with Taisho; receives milestone payment from Chiesi
Read More
Dutch and U.S. alliance formed for familial hypercholesterolemia gene therapy
Read More
Immusol and Chugai establish functional genomics alliance
Read More
Genta begins new phase III with Genasense for treatment of CLL
Read More
Chelating drug to be codeveloped by Biomedical Frontiers and Chiesii
Read More
InterMune's Actimmune enters phase II for treatment of cystic fibrosis
Read More
Recently discovered protein for obesity expected to enter clinical trials in 2001
Read More
Relationship between CCK and functional dyspepsia examined using CCK-A antagonist
Read More
New triptan available for migraine therapy in the U.K.
Read More
Metformin during pregnancy safely reduces early spontaneous abortion in PCOS patients
Read More
Herzyme IND filed in Canada; Ribozyme anticipates initiation of phase I trials in Vancouver
Read More
D-Pharm and Lilly establish CNS collaboration
Read More
DepoCyt again available in the U.S. for lymphomatous meningitis
Read More
NCI supports development of Targesome's nanoparticle-based diagnostic imaging agents
Read More
CeNeS cleared to commence clinical trial of treatment for alcohol addiction
Read More
Non-CB1/CB2 cannabinoid receptor ligands and use in cardiovascular disorders
Read More
Nikken researchers describe new selective PDE4 inhibitors
Read More
Heterocyclic compounds from Sankyo act as Th1-selective immunosuppressants
Read More
U.S. and Japanese pharmaceutical companies pool resources to develop new antiviral agents
Read More
Merck KGaA presents new benzoylpyridazines as PDE4 and TNF inhibitors
Read More
Regulatory submissions filed for novel STI targeting abnormal protein in CML
Read More
Antineoplastic coumarone analogues identified at Sankyo
Read More
Antiinflammatory compounds in the Eisai pipeline
Read More
Anti-H. pylori dioxopiperazines discovered at Yamanouchi
Read More